回上页
To Prescribe or Not to Prescribe: Sunitinib ‘Off Label’ Prescription for Relapse and Unresectable Liver Cancer Patient Who Outlived Typical Prognosis by Many Years Found Not to Constitute Professional Misconduct
25 August 2025

关注天博领英页面
香港金钟道88号太古广场1座16楼
T +852 25232003
F +852 28100302